The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of GlaxoSmithKline's 2013 sales performance.
GlaxoSmithKline (GSK) and Medicago have started phase 3 clinical testing of their plant-based adjuvanted COVID-19 vaccine.
GlaxoSmithKline (GSK) and Vir Biotechnology are seeking an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for their COVID-19 a monoclonal antibody (mAb) VIR-7831 after
British drugmaker GlaxoSmithKline (GSK) and Vir Biotechnology have announced that they will pause enrolment for the treatment arm of a phase 3 trial evaluating their investigational COVID-19 antibody VIR-7831.
In February, CureVac then signed a deal with British drugmaker GlaxoSmithKline (GSK) to develop the next generation of mRNA-based COVID-19 vaccines.
countries. In addition, if other COVID-19 vaccine candidates are found to be safe and effective in clinical trials – such as candidates from GlaxoSmithKline/Sanofi and/or Curevac – an additional one
[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]
Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...